MDA funds Catabasis to test therapies for muscle disorder
MDA translational research director Jane Larkindale said the grant will help to support further testing of CAT-1004 to assess the compound’s ability to counter muscle-damaging inflammation and support
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.